Trypan Blue Free Acid

Trypan Blue Free Acid

SCHEMBL29355441

Cc1cc(-c2ccc(N=Nc3c(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(N)c4c3O)c(C)c2)ccc1N=Nc1c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(N)c2c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 1.00
▸ KMT2A Q03164 2/20 1.00
▸ HTT P42858 1/20 1.00
▸ PHLPP2 Q6ZVD8 2/20 0.82
▸ ENPP2 Q13822 9/20 0.76
▸ PTPN1 P18031 2/20 0.74
▸ USP2 O75604 1/20 0.74
▸ ATM Q13315 1/20 0.74
▸ L3MBTL1 Q9Y468 1/20 0.74
▸ CYP1A2 P05177 2/20 0.60
▸ SUMO2 P61956 1/20 0.59
▸ SUMO1 P63165 1/20 0.59
▸ SENP7 Q9BQF6 1/20 0.59
▸ SENP3 Q9H4L4 1/20 0.59
▸ SENP2 Q9HC62 1/20 0.59
▸ SENP1 Q9P0U3 1/20 0.59
▸ PRMT1 Q99873 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.53
▸ CYP2C9 P11712 2/20 0.53
▸ MAPK1 P28482 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trypan Blue Free Acid SCHEMBL29376676 1.00 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
Trypan Blue Free Acid SCHEMBL15497820 1.00 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
Trypan Blue Free Acid SCHEMBL12234090 1.00 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
Trypan Blue Free Acid SCHEMBL29415031 1.00 MEN1 (1.00) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL13243797 0.97 MEN1 (0.94) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL24438814 0.93 MEN1 (0.87) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL18784959 0.92 MEN1 (0.85) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL21105389 0.92 MEN1 (0.85) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL20128454 0.92 MEN1 (0.85) MEN1KMT2AHTTPHLPP2ENPP2
SCHEMBL14215680 0.92 MEN1 (0.85) MEN1KMT2AHTTPHLPP2ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240325421-A1 PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS NISIBIS, LLC-S 2024-10-03 — — US claimed
US-12036230-B2 PTEN inhibitors for treatment and prevention of bone marrow loss NISIBIS, LLC-S (US) 2024-07-16 — — US claimed
CN-117799028-A Dyeing method of medium-density fiberboard 坤彩数码科技(天津)有限公司 2024-04-02 — — CN claimed
CN-114867791-B Colored curable composition 住友化学株式会社 2023-12-05 — — CN claimed
CN-115960493-B Weather-resistant cyan ink-jet ink 郑州鸿盛数码科技股份有限公司 2023-11-10 — — CN claimed
US-20230218653-A1 PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS NISIBIS, LLC-S 2023-07-13 — — US claimed
CN-115960493-A Weather-resistant cyan ink-jet ink 郑州鸿盛数码科技股份有限公司 2023-04-14 — — CN claimed
US-11572485-B2 Ink set SEIKO EPSON CORPORATION 2023-02-07 — — US claimed
US-11434386-B2 Water-based ink for ink-jet recording BROTHER KOGYO KABUSHIKI KAISHA (JP) 2022-09-06 — — US claimed
EP-3434739-B1 SUBLIMATION TRANSFER INK JET INK COMPOSITION AND SUBLIMATION TRANSFER INK JET RECORDING METHOD SEIKO EPSON CORP (JP) 2022-08-10 — — EP claimed
CN-114867791-A Colored curable composition 住友化学株式会社 2022-08-05 — — CN claimed
CN-110520303-B Ink jet recording method and ink jet recording apparatus 佳能株式会社 2022-06-07 — — CN claimed
WO-2022047196-A1 PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS NISIBIS, LLC-S (US) 2022-03-03 — — WO claimed
CN-109321037-B Ink for ink jet textile printing and ink set for ink jet textile printing 精工爱普生株式会社 2022-02-15 — — CN claimed
US-20260145439-A1 INK JET RECORDING METHOD AND INK JET RECORDING APPARATUS CANON KABUSHIKI KAISHA (JP) 2026-05-28 — — US disclosed
EP-4748577-A1 STORAGE BAG BROTHER KOGYO KABUSHIKI KAISHA (JP) 2026-05-27 — — EP disclosed
EP-4748578-A1 INK CARTRIDGE BROTHER KOGYO KABUSHIKI KAISHA (JP) 2026-05-27 — — EP disclosed
US-20220033666-A1 Treatment Liquid Composition For Ink Jet Pigment Printing, Ink Set, And Recording Method SEIKO EPSON CORPORATION (JP) 2022-02-03 — — US disclosed
US-20220024219-A1 INK JET RECORDING METHOD AND INK JET RECORDING APPARATUS CANON KABUSHIKI KAISHA (JP) 2022-01-27 — — US disclosed
EP-3943556-A1 DYE INK COMPOSITION, DYE INK FOR INK JET RECORDING, AND INK JET RECORDING METHOD FUJIFILM Corporation (JP) 2022-01-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260145439-A1 INK JET RECORDING METHOD AND INK JET RECORDING APPARATUS TAS1R2, TAS2R30, IK MEN1 1440/4885KMT2A 1830/4885HTT 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback